InsidersTradesSigma
Browse the complete record of transactions filed by Blount Sally E., Director. Officer active across 1 companies, notably Abbott Laboratories. Aggregated, 1 reports have been logged. The latest transaction was disclosed on 29 April 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
Blount Sally E. is a Board Member at Abbott Laboratories. She participates in the governance of the company, bringing her expertise to guide strategic decisions and ensure regulatory compliance.